For information on migraine clinical trials, please contact Maxime Boutin-Caron.
Current Recruiting Studies
Active Studies (not recruiting)
The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic migraine.
This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.